Shelf Life of Unani Drugs: In Classical and Contemporary Era

Authors

  • Seema Rani Jamia Hamdard deemed University
  • Khaleequr Rahman
  • Peerzada Mohd. Younis
  • Mohd. Shadab

Keywords:

shelf life, unani, stability

Abstract

Nothing in this universe is immortal. Drugs also degrade with time. Thus significance and indispensability of stability testing is well recognized since ancient time. However, in the absence of sophisticated scientific technology ancient Unani physicians used to evaluate the shelf life of drugs by means of organoleptic characters. In this paper review of classical Unani literature of plants, minerals and animal origin and compound drugs has been discussed in detail in all classical Unani anthologies and Contemporary Era. Eminent Unani scholars have discussed about stability and shelf life in their respective valuable compilations and treatises. They also discussed the way to improve the shelf life and preservation techniques. Later on government of India, Dept. of AYUSH, has also stated that the potency of ASU preparations is lost / reduced after a certain period of time. It is recommended that expiry date for ASU drugs shall be clearly displayed on the label of container or package of an Ayurvedic, Siddhas and Unani drugs. After expiry date they shall not be in circulation. Dept. of AYUSH also amend drug and cosmetics rules, 1945, rule 161B, (Amendment, dated 24th November, 2005) and states the shelf life of drugs as per their dosage form. However, the shelf life mentioned in Unani classical text, National formulary as well as in Drug and Cosmetics Rules is empirical. Thus, it is the need of the hour to find out the stability of drugs on modern scientific parameters so that the shelf life can be decided logically.

Author Biography

  • Seema Rani, Jamia Hamdard deemed University
    Associate Professor, School of Unani Medical Education & Research, Jamia Hamdard

References

Donell PBO, Bokser AD. Stability of pharmaceutical products. In: Troy DB (Ed). Remington-The Science and Practice of Pharmacy, 21st Edn. Philladelphia: Lippincott Williams and Wilkins. 2006; 1: 1025–36p.

Vadas EB. Stability of pharmaceutical product. In: Genarro (Ed). Remington–The Science and Practice of Pharmacy. 20th edn. Philladelphia: Lippincott Williams and Wilkins. 2000; 1: 986p.

Ali A. Qarabadeen Ahsaani. New Delhi: CCRUM. Cass Enterprises. 2006; 4p.

Jilani G. Mukhzanul Murakkabat. New Delhi: Aijaz Publishing House. 1995; 1p.

Hamarneh SK, Sonnedecker GA. A pharmaceutical view of Abulcasis Al–Zahrāwī in Moorish Spain: With Special Reference to the “Adhān.” Netherlands: Brill Archive. 1963; 66p.

Tabri AHR. Firdausul Hikmat, 1st Edn. Deoband: Faisal Publication. 2002; 390p.

Razi ABZ. Al Hawi fit Tibb. Vol IX. New Delhi: Central Council for Research in Unani Medicine. 1971; 1: 43–59p.

Majoosi AA. Kamilus Sana (Urdu trans. by Kantoori GH). New Delhi: Idarae Kitabus Shifa. 2010; I & II: 491–92p.

Ibn Sina. Al Qanoon fit Tibb (Urdu trans. by Kantoori GH). New Delhi: Eijaz Publication House. 2010; 1458–59p.

Kabeeruddin M. Kulliyat Advia. Lahore: Malik Deen Mohd and Sons. 1958; 28: 181–88p.

Lateef A. Tozeehaat Kulliyat e Advia. Aligarh. Ibne Seena Academy of Medieval Medicine & Sciences, Tijara House; 2002; 262–67p.

Said H. Hamdard Pharmacopoeia of Eastern Medicine. New Delhi: Sri Satguru Publishers. 1970; 152p.

Ghani N. Khazainul Advia. New Delhi: Idara Kitabus Shifa. 1971; 1: 701–02, 785–88, 1268, 1273–74p.

Hamarneh SK, Sonnedecker GA. A Pharmaceutical View of Abulcasis Al–Zahrāwī in Moorish Spain: With Special Reference to the “Adhān.”" Netherlands: Brill Archive; 1963; 66p.

Multani HC, Khan FNK. Hindustan wa Pakistan ki Jadi Bootiyan. Delhi: Central Dawakhana Lahore; YNM. Preface V111p..

Shirazi MHKM. Qarabadin Kabir. 1st vol. 1st ed. Delhi: Hafiz Niyaz Ahmad Publisher India;1892. p45–6.

Arzani H A. Qarabadeen Qadri. New Delhi: Aijaz Publishing House. 1998; 8, 9, 10, 15, 17, 37, 53, 54, 56, 58, 60, 61, 65, 66, 184, 185, 190, 191, 206, 492, 511p.

National Formulary of Unani Medicine. Part 1. New Delhi: Central Council of Research in Unani Medicine. 2006; 67, 178, 188, 210, 229p.

Gazette Notification issued under the Drugs and Cosmetics Rule 1945. Available at URL: http://indianmedicine.nic.in/writereaddata/mainlinkFile/File337.pdf [Accessed on 19–3–13].

Drugs and Cosmetics (Amendment) Rules 2005, Rule 161B, Notification. 24th Nov, 2005. New Delhi: Ministry of Health and Family Welfare. Available at URL:http://amamayurveda.org/pdf/shelf_life_notification_241105_.pdf.

Final Draft. Shelf–life Recommendations for Supplements Guidelines for Manufacturers 27.11.13. Available at URL: https://unpa.com/assets/news_resource/asset/5/ Shelf_life_recommendations _for_supplements_27.11.13.pdf [Accessed on 12.01.14].

Yoshioka S, Stella VJ. Stability of Drugs and Dosage Forms. India Springer. 2009; 1p.

Kennon LJ. Use of models in determining chemical pharmaceutical stability. J Pharm Sci.1964; 53(7): 815–18p.

Baertschi SW. Pharmaceutical Stress Testing. Taylor and Francis, Boca Raton. 2008; 5p.

Grimm W. Extension of the international conference on harmonization tripartite guideline for stability testing of new drug substances and products to countries of climatic zones III and IV. Drug Dev Ind Pharm. 1998; 24(4): 313–25p.

Seevers RH. Regulatory strategy for long–term stability conditions to support submission in zone IV countries. Pharmaceutical Outsourcing. 2011; 12(2). Available at: URL:http://www. pharmoutsourcing.com/ Featured-Articles/37672-Regulatory-Strategy-for-Long-Term-StabilityConditions-to-Support-Submission-in-Zone-IV-Countries/ [Accessed on 18–05–14].

ICH Q1A(R2). Stability Testing of New Drug Substances and Products. 2003. Available at: URL:http://www.ich.org/fileadmin/PublicWeb_Site/ICH_Products/Guidelines/Quality/Q1A_R2/Step4/Q1A_R2_Guideline.pdf (Accessed on 26.03. 2012).

ICH. Q1C. Stability Testing for New Dosage Forms. 1996. Available atURL:http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q1C/Step4/Q1C_Guideline.pdf (Accessed on 26.03.2012).

Huynh–Ba K. Hand Book of Stability Testing in Pharmaceutical Testing. New Delhi: Springer. 2011; 66–67p.

Cartenson JT, Rhodes C. Drug Stability Principles and Practices, 3rd Edn. New York: Taylor & Francis. 2000; 3, 289p.

Downloads

Published

2015-06-27

Issue

Vol. 2 No. 2 (2015)

Section

Review Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.